JPH01185266A - Liquid transfusion device - Google Patents
Liquid transfusion deviceInfo
- Publication number
- JPH01185266A JPH01185266A JP63009053A JP905388A JPH01185266A JP H01185266 A JPH01185266 A JP H01185266A JP 63009053 A JP63009053 A JP 63009053A JP 905388 A JP905388 A JP 905388A JP H01185266 A JPH01185266 A JP H01185266A
- Authority
- JP
- Japan
- Prior art keywords
- infusion
- bottle
- contamination
- injection needle
- transfusion liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title abstract description 13
- 238000011109 contamination Methods 0.000 claims abstract description 39
- 229920000642 polymer Polymers 0.000 claims abstract description 12
- 238000001802 infusion Methods 0.000 claims description 77
- 230000003449 preventive effect Effects 0.000 claims description 2
- 229920001971 elastomer Polymers 0.000 abstract description 23
- 239000007924 injection Substances 0.000 abstract description 22
- 238000002347 injection Methods 0.000 abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 8
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 239000003242 anti bacterial agent Substances 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 description 30
- 241000894006 Bacteria Species 0.000 description 6
- 239000003978 infusion fluid Substances 0.000 description 6
- 239000012530 fluid Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 238000010586 diagram Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- BRLSVBQUGGJOLL-UHFFFAOYSA-N (4-aminophenyl)sulfonyl-pyrimidin-2-ylazanide;cerium(3+) Chemical compound [Ce+3].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1.C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1.C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 BRLSVBQUGGJOLL-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000006833 reintegration Effects 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229960001516 silver nitrate Drugs 0.000 description 1
- 229960003600 silver sulfadiazine Drugs 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 210000001321 subclavian vein Anatomy 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- RXXROIWDLGTUIN-UHFFFAOYSA-N zinc;(4-aminophenyl)sulfonyl-pyrimidin-2-ylazanide Chemical compound [Zn+2].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1.C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 RXXROIWDLGTUIN-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
【発明の詳細な説明】
イ、産業上の利用分野
本発明は、輸液装置に関し、例えば医療用の輸液装置に
関する。DETAILED DESCRIPTION OF THE INVENTION A. Field of Industrial Application The present invention relates to an infusion device, for example, a medical infusion device.
口、従来技術
手術前後の栄養補給や消化器機能不全者の栄養確保のた
め、高カロリー輸液を生体に供給(投与)すること(T
otal Perenteral Nutrition
)や経腸輸液を生体に投与すること(Enteral
Nutrition )がなされる。経腸輸液の投与は
、消化器機能不全者や大手術を受けた患者の健康回復を
促進して社会復帰を速めるために必要な処置である。Conventional technology Supplying (administering) high-calorie infusions to living organisms to provide nutritional support before and after surgery, or to secure nutrition for patients with digestive system dysfunction (T
otal Parenteral Nutrition
) or administering enteral infusions to a living body (Enteral
Nutrition) is performed. Administration of enteral fluids is a necessary procedure for promoting health recovery and hastening social reintegration in patients with gastrointestinal dysfunction or patients who have undergone major surgery.
これらの輸液は、栄養剤を無菌水に熔解してなるもので
あって、容器(瓶)に入れられ、これに接続する輸液導
管、更にカテーテルを経由して患者の体内に投与される
。瓶と輸液導管との接続は次のようにしてなされる。瓶
の底は下線がりになっていて、その先端は開口されてお
り、この開口部にゴムの栓が嵌入して瓶からの輸液の排
出を防止している。輸液導管の先端には注射針が接続し
ていて、注射針にはその位置決めをするためのフランジ
が固定されている。注射針とフランジとからなる部分は
瓶針と呼ばれている。注射針を瓶のゴム栓に突刺してフ
ランジをゴム栓に当接させると、注射針の先端は瓶内部
に到達し、瓶と輸液導管とが導通し、瓶内の輸液は輸液
導管を通って患者の体内に投与される。These infusion solutions are made by dissolving nutritional supplements in sterile water, and are placed in a container (bottle) and administered into the patient's body via an infusion conduit connected to the container and further through a catheter. The connection between the bottle and the infusion conduit is made as follows. The bottom of the bottle is underlined, and the tip is open, and a rubber stopper fits into this opening to prevent the infusion from draining out of the bottle. A syringe needle is connected to the tip of the infusion conduit, and a flange for positioning the syringe needle is fixed to the syringe needle. The part consisting of the injection needle and flange is called the bottle needle. When the syringe needle is inserted into the rubber stopper of the bottle and the flange is brought into contact with the rubber stopper, the tip of the syringe needle reaches the inside of the bottle, the bottle and the infusion conduit are connected, and the infusion in the bottle passes through the infusion conduit. The drug is then administered into the patient's body.
しかしながら、患者の移動や睡眠中の動作(寝返りその
他)によって注射針がゴム栓から抜けることがある。こ
れを防止するためにベルトをフランジに当てて、このヘ
ルドを皿支持用の支柱に掛けるようにしている。そのほ
か、注射針に替えてプラスチック製の太い針を使用する
ことも、広く試みられている。However, the needle may come out of the rubber stopper due to patient movement or movement during sleep (turning over, etc.). To prevent this, a belt is placed against the flange, and the heald is hung on a column for supporting the dish. In addition, the use of thick plastic needles in place of syringe needles has also been widely attempted.
ところが、従来の方法ではゴム栓から針の抜き出しを防
止できたとしても、針をゴム栓に突き刺すときや瓶中の
輸液が消費し尽(されてゴム栓から針を抜くときに、輸
液が飛散することがある。However, with conventional methods, even if it is possible to prevent the needle from being pulled out of the rubber stopper, when the needle is inserted into the rubber stopper, or when the infusion in the bottle is used up (and the needle is removed from the rubber stopper), the infusion may scatter. There are things to do.
また、ゴム栓は、繰返し使用しているうちに、針との間
で輸液の漏洩が起こるようになる。上記の飛散した、或
いは漏洩した輸液が、培地となって、菌の繁殖が起こり
やすく、また、輸液導管及びカテーテルを伝わってライ
ンを汚染し、これが培地となって菌が繁殖しやすく、無
菌管理上甚だ不都合である。特に、血液へ高カロリー輸
液を直接投与する場合は、菌の侵入は患者にとって極め
て危険である。上記の菌やその繁殖による輸液導管その
他の汚染を防止するためには、オペレータ(看護婦)が
常時上記の不所望な輸液を拭い取るなどせねばならず、
オペレータの負担が大きくなる。Further, as the rubber stopper is used repeatedly, infusion fluid may leak between the rubber stopper and the needle. The above-mentioned scattered or leaked infusion fluid becomes a culture medium, which is likely to cause the propagation of bacteria, and it also travels through the infusion conduit and catheter, contaminating the line, which becomes a culture medium, which makes it easy for bacteria to propagate, and sterile management is required. Moreover, it is extremely inconvenient. Particularly when high-calorie infusions are administered directly into the blood, bacterial invasion is extremely dangerous to the patient. In order to prevent the above-mentioned bacteria and their proliferation from contaminating the infusion conduit and other areas, the operator (nurse) must constantly wipe off the above-mentioned unwanted infusion fluid.
This increases the burden on the operator.
ハ8発明の目的
本発明は、上記の事情に鑑みてなされたものであって、
輸液が飛散したり漏れたりしても、菌やの作業からオペ
レータを開放して省力化を可能とする輸液装置を提供す
ることを目的としている。C.8 Purpose of the Invention The present invention has been made in view of the above circumstances, and includes:
The purpose of the present invention is to provide an infusion device that can save labor by freeing an operator from working with bacteria even if the infusion is scattered or leaks.
二9発明の構成
本発明は、輸液を収容する容器と、この容器に接続する
輸液導管と、前記容器と輸液導管との接続部の漏液を吸
収してこの漏液による汚染を防止する吸水性ポリマーよ
り成形された汚染防止具とを有する輸液装置に係る。29 Structure of the Invention The present invention provides a container for storing an infusion solution, an infusion conduit connected to the container, and a water absorption system that absorbs leakage from a connection between the container and the infusion conduit to prevent contamination due to the leakage. The present invention relates to an infusion device having a contamination prevention device molded from a synthetic polymer.
ホ、実施例 以下、本発明の詳細な説明する。E, Example The present invention will be explained in detail below.
第15図に輸液装置の概略図を示す。FIG. 15 shows a schematic diagram of the infusion device.
高カロリー輸液TPNL (又は経腸輸液ENL)は瓶
6中に収容され、瓶6の底部に第一の輸液導管7が接続
している。この接続については、後に第1図、第2図に
よって詳述する。第一の輸液溝管7には流量調節器8、
第二の輸液導管17、コネクタ10、カテーテル(第三
の輸液導管)27が順次接続し、輸液TPN、Lは上記
各部を経由して第16図に示す如く患者の体内に投与さ
れる。The high-calorie infusion TPNL (or enteral infusion ENL) is contained in a bottle 6, to the bottom of which a first infusion conduit 7 is connected. This connection will be explained in detail later with reference to FIGS. 1 and 2. The first infusion groove tube 7 includes a flow rate regulator 8;
The second infusion conduit 17, the connector 10, and the catheter (third infusion conduit) 27 are connected in sequence, and the infusions TPN and L are administered into the patient's body via the above-mentioned parts as shown in FIG.
図中、27aはカテーテル先端部、71は心臓、72は
中心静脈、73は鎖骨下静脈である。In the figure, 27a is a catheter tip, 71 is a heart, 72 is a central vein, and 73 is a subclavian vein.
瓶6と第一の輸液導管(以下、単に輸液導管と呼ぶ。)
7との接続は、第1図及び第2図に示すようにしてなさ
れる。第1図は瓶6と輸液導管7とを接続した状態を、
第2図は瓶6と輸液導管7との接続直前の状態を夫々示
す拡大断面図である。Bottle 6 and the first infusion conduit (hereinafter simply referred to as the infusion conduit)
7 is made as shown in FIGS. 1 and 2. Figure 1 shows the state in which the bottle 6 and the infusion conduit 7 are connected.
FIG. 2 is an enlarged sectional view showing the state immediately before the bottle 6 and the infusion conduit 7 are connected.
瓶6の底部は下線がりとなっていて円筒部6aが設けら
れ、円筒部6aには弾性を有するプラスチック製キャッ
プ5が密着して外嵌し、キャップ5内にゴム栓4が瓶6
の円筒部6aに当接するように嵌太し、第2図に示すよ
うに瓶6内の高カロリー輸液TPNLの落下を防止して
いる。また、キャップ5とゴム栓4とは、下端面が略同
−平面上に位置するようにしである。The bottom of the bottle 6 is underlined and provided with a cylindrical part 6a, an elastic plastic cap 5 is tightly fitted onto the cylindrical part 6a, and a rubber stopper 4 is fitted inside the cap 5 to secure the bottle 6.
The cylindrical portion 6a of the bottle 6 is fitted to prevent the high-calorie infusion TPNL from falling as shown in FIG. Further, the cap 5 and the rubber stopper 4 are arranged so that their lower end surfaces are located on substantially the same plane.
注射針1には貫通孔を設けた弾性を有するブラスチソク
製フランジ2が密着して外嵌している。An elastic plastic flange 2 having a through hole is tightly fitted onto the injection needle 1.
フランジ2は、円板状汚染防止具3の貫通孔に嵌入する
先端部2a、フランジ部2b及び輸液導管7に嵌入する
後端部2Cとからなっていて、後端部2Cが輸液導管7
に嵌入して注射針1と輸液導管7とが導通する。汚染防
止具3はスポンジ状を呈していて吸水性を有する。The flange 2 consists of a distal end portion 2a that fits into the through hole of the disc-shaped contamination prevention device 3, a flange portion 2b, and a rear end portion 2C that fits into the infusion conduit 7.
The injection needle 1 and the infusion conduit 7 are connected to each other. The pollution prevention tool 3 has a sponge-like shape and has water absorbing properties.
第2図の状態から、汚染防止具3にフランジ2の先端部
2aを嵌入させ、注射針1をゴム栓4に突刺して注射針
1の先端部を瓶6内に侵入させると、第1図に示すよう
に、汚染防止具3は、キャップ5、ゴム栓4及びフラン
ジ部2bに密着し、先端部が瓶6内に侵入した注射針1
によって瓶6と輸液導管7とが導通し、瓶6内の高カロ
リー輸液TPNLは、注射針1、輸液導管7を経由して
、第15図、第16図のように患者の体内に供給される
。From the state shown in FIG. 2, when the tip 2a of the flange 2 is fitted into the contamination prevention device 3, the injection needle 1 is inserted into the rubber stopper 4, and the tip of the injection needle 1 enters the bottle 6, the first As shown in the figure, the contamination prevention device 3 is in close contact with the cap 5, the rubber stopper 4, and the flange portion 2b, and the injection needle 1 whose tip has penetrated into the bottle 6
The bottle 6 and the infusion conduit 7 are connected to each other, and the high-calorie infusion TPNL in the bottle 6 is supplied into the patient's body via the injection needle 1 and the infusion conduit 7 as shown in FIGS. 15 and 16. Ru.
汚染防止具3は、例えば吸水倍率10〜1000倍(体
積比)程度の高吸水性を有するポリマーから形成され、
かつ抗菌剤を含有していることが好ましい。上記のポリ
マーとしては、アクリル酸系、メタクリル酸系ポリマー
、アクリルアミド系ポリマー、澱粉−ポリアクリル酸系
グマフトボリマー、エチレンオキサイド系ポリマー、ビ
ニルアルコール系ポリマー、カルボキシメチルセルロー
ス系ポリマー等が挙げられる。また、上記の材料を、ゴ
ム又はプラスチックの単量体若しくは複合体に混合して
なる材料も使用できる。上記抗菌剤としては、スルファ
ジアジン銀、スルファジアジン亜鉛、スルファジアジン
セリウム、硝酸銀、ゲンタマイシン等が挙げられる。ま
た、汚染防止具3の寸法は、外径10璽窟、内径4mm
、厚さ2fI、吸水倍率は約20倍としである。The pollution prevention tool 3 is formed from a polymer having high water absorption, for example, with a water absorption capacity of about 10 to 1000 times (volume ratio),
It also preferably contains an antibacterial agent. Examples of the above polymers include acrylic acid-based polymers, methacrylic acid-based polymers, acrylamide-based polymers, starch-polyacrylic acid-based polymers, ethylene oxide-based polymers, vinyl alcohol-based polymers, carboxymethyl cellulose-based polymers, and the like. Moreover, a material obtained by mixing the above-mentioned materials with a rubber or plastic monomer or composite can also be used. Examples of the antibacterial agents include silver sulfadiazine, zinc sulfadiazine, cerium sulfadiazine, silver nitrate, and gentamicin. In addition, the dimensions of the pollution prevention tool 3 are an outer diameter of 10 mm and an inner diameter of 4 mm.
, the thickness is 2fI, and the water absorption capacity is approximately 20 times.
輸液装置を上記のように構成することにより、高カロリ
ー輸液TPNLが前述したように飛散したり或いは注射
針とゴム栓3との間から漏れたとしても、外部に出た高
カロリー輸液は、汚染防止具3に吸収され、輸液導管7
の外面を伝わって患者側に移動することがなく、輸液導
管7等の汚染が防止される。その上、汚染防止具3は抗
菌剤を含有しているので、大気中の菌が侵入しても、菌
が死滅し、繁殖することもない。従って、輸液投与が安
全に遂行され、看護婦の汚染防止のための作業が不要と
なって、この煩わしい作業から解放される。更に、汚染
防止具は、漏液を吸収して体積が増えるので、漏液を飽
和して交換すべき時期を外部からの観察によって容易に
知ることができ、この磁気に汚染防止具の交換をすれば
足り、輸液装置の他の部分を交換する必要がない。By configuring the infusion device as described above, even if the high-calorie infusion TPNL scatters as described above or leaks from between the injection needle and the rubber stopper 3, the high-calorie infusion that comes out will not be contaminated. It is absorbed by the preventer 3 and the infusion conduit 7
The liquid does not travel to the patient side along the outer surface of the infusion tube 7, and contamination of the infusion conduit 7 and the like is prevented. Moreover, since the contamination prevention tool 3 contains an antibacterial agent, even if bacteria in the atmosphere invade, the bacteria will be killed and will not reproduce. Therefore, infusion administration can be carried out safely, and the nurse does not have to work to prevent contamination, which relieves the nurse from this troublesome work. Furthermore, since the contamination prevention tool absorbs leakage liquid and increases in volume, it is easy to tell by external observation when the leakage liquid has saturated and it is time to replace the contamination prevention device. There is no need to replace other parts of the infusion device.
第3図は、汚染防止具13の内径を小さくして注射針1
に直接外嵌するようにし、注射針1とゴム栓4との間で
矢印のように漏れた高カロリー輸液TPNLを、フラン
ジ2との界面を経由することなく直接汚染防止具13に
よってより効果的に吸収するようにした例を示す。この
例では、汚染防止具13はフランジ2の先端部2aの端
面に当接する。FIG. 3 shows a hypodermic needle 1 with a smaller inner diameter of the contamination prevention tool 13.
The high-calorie infusion TPNL that leaks between the injection needle 1 and the rubber stopper 4 as shown by the arrow is directly fitted onto the outside of the injection needle 1 and the rubber stopper 4 without passing through the interface with the flange 2, making it more effective. An example is shown below. In this example, the contamination prevention tool 13 comes into contact with the end surface of the tip 2a of the flange 2.
第4図の例では、フランジ12は、先端部を省略し、後
端部12cに汚染防止具23を外嵌せしめている。注射
針1とゴム栓4との間から漏れた高カロリー輸液は、図
中矢印のようにフランジ12のフランジ部+2bの表面
を伝わって汚染防止具23に吸収される。この例では、
第5図に示すように、支柱19のフック19aにベルト
18が掛けられ、汚染防止具23はベルト18に支承さ
れて瓶6と共に支柱19に支持される。このようにして
、輸液導管7及びその中の輸液TPNLその他の重量に
よって注射針1がゴム栓4から抜出すのが防止される。In the example shown in FIG. 4, the flange 12 has a leading end portion omitted, and a contamination prevention tool 23 is fitted onto the rear end portion 12c. The high-calorie infusion leaking from between the injection needle 1 and the rubber stopper 4 is absorbed into the contamination prevention device 23 through the surface of the flange portion +2b of the flange 12 as shown by the arrow in the figure. In this example,
As shown in FIG. 5, the belt 18 is hung on the hook 19a of the support column 19, and the contamination prevention tool 23 is supported by the belt 18 and supported by the support column 19 together with the bottle 6. In this way, the weight of the infusion conduit 7 and the infusion TPNL and others therein prevents the injection needle 1 from being pulled out of the rubber stopper 4.
ヘルド18は、第6図に示すように、フランジ12の後
端部12c (第4図参照)が嵌入する貫通孔18a及
び支柱19のフック19a(第5図参照)に掛けるため
の複数の貫通孔18bを有し、貫通孔18aの周囲の領
域には汚染防止具23が貼付してあって、汚染防止具2
3のセントを容易ならしめている。As shown in FIG. 6, the heald 18 has a through hole 18a into which the rear end 12c of the flange 12 (see FIG. 4) is fitted, and a plurality of through holes for hanging onto the hooks 19a of the struts 19 (see FIG. 5). It has a hole 18b, and a contamination prevention tool 23 is attached to the area around the through hole 18a.
It makes 3 cents easy.
第7図は、ベルト28(又は38)を汚染防止具33の
両側から上方に延ばし、第8図又は第10図に示すよう
に、支柱19又は19Bのフック19a又は水平部分1
9bにベルトの両端部を掛けるようにし、ベルト28又
は38による注射針1のゴム栓4からの抜出しをより効
果的に防止した例を示す。第9図、第11図はヘルド2
8.38を夫々示す。ベルト28にはフランジ12の後
端部12C(第7図参照)が嵌入する貫通孔28aが設
けられ、貫通孔28aの両側には第8図のビン18dに
よって上記両側を合わせて固定するための一対の貫通孔
28C128cが設けられ、一方の貫通孔28Cの一方
の側には支柱19のフック19a(第8図参照)に掛け
るための貫通孔18bが複数段けである。ベルト38に
はベルト28の貫通孔28aと同様の貫通孔38aが設
けられ、その両側には支柱19Bの水平部19b(第1
0図参照)に掛けるための貫通孔38bが複数個対称位
置に設けである。貫通孔28a、38aの周囲の領域に
は、第6図に於けると同様に、汚染防止具33が貼付し
である。その他は第4図〜第6図に於けると同様である
。FIG. 7 shows that the belt 28 (or 38) is extended upwardly from both sides of the contamination preventive device 33, and the hook 19a or horizontal portion 1 of the support column 19 or 19B is
An example is shown in which both ends of the belt are hung on the belt 9b to more effectively prevent the injection needle 1 from being pulled out from the rubber stopper 4 by the belt 28 or 38. Figures 9 and 11 are Heald 2
8.38 are shown respectively. The belt 28 is provided with a through hole 28a into which the rear end 12C (see FIG. 7) of the flange 12 is fitted, and on both sides of the through hole 28a there are screws 18d shown in FIG. 8 for fixing the two sides together. A pair of through holes 28C128c are provided, and one side of one of the through holes 28C has a plurality of through holes 18b for hanging onto hooks 19a (see FIG. 8) of the support column 19. The belt 38 is provided with a through hole 38a similar to the through hole 28a of the belt 28, and horizontal portions 19b (first
A plurality of through-holes 38b are provided at symmetrical positions for hanging the cable (see Figure 0). A contamination prevention device 33 is attached to the area around the through holes 28a, 38a, as in FIG. 6. Other details are the same as in FIGS. 4 to 6.
第1図、第2図の例では、前述したように、汚染防止具
3の寸法を、外径101m、内径4+n、厚さ21mと
しているが、汚染防止具の寸法は、上記の寸法に限られ
るものではなく、外径5〜80i+i、厚さ0.5〜1
011の範囲内の適宜の寸法として良い。In the examples shown in FIGS. 1 and 2, as mentioned above, the dimensions of the contamination prevention tool 3 are 101 m in outer diameter, 4+n in inner diameter, and 21 m in thickness, but the dimensions of the contamination prevention tool are limited to the above dimensions. outer diameter 5~80i+i, thickness 0.5~1
An appropriate size within the range of 0.011 may be used.
内径は、フランジの先端部若しくは後端部又は注射針が
嵌入する適宜の寸法として良い。また、第12図及び第
13図に示すように、汚染防止具43.53の形状は、
円板状のほか、円筒形、Oリングの形状とすることもで
きる。その他、シート状、パツキン状でも良い。更に、
第14図に示すように、円板状汚染防止具63に、貫通
孔63aから外周面に達する切欠き63bを設け、注射
針をゴム栓に突刺してこれを瓶に接続した後、フランジ
の先端部若しくは後端部又は注射針に切欠き63bを経
由して貫通孔63aを外嵌させ、汚染防止具63をセン
トする。このように最後に汚染防止具63をセットする
ようにして、これをセント後に着脱可能にし、汚染防止
具63が漏れた輸液を飽和するようになったときは、こ
れを外して新しい汚染防止具と交換するようにでき、輸
液投与を中断することなく続行することができる。The inner diameter may be an appropriate size that allows the tip or rear end of the flange or the injection needle to fit therein. Moreover, as shown in FIGS. 12 and 13, the shape of the pollution prevention tool 43.53 is as follows.
In addition to the disk shape, it can also be cylindrical or O-ring shaped. In addition, it may be in the form of a sheet or a package. Furthermore,
As shown in FIG. 14, a notch 63b extending from the through hole 63a to the outer peripheral surface is provided in the disc-shaped contamination prevention device 63, and after the injection needle is inserted into the rubber stopper and connected to the bottle, the flange is inserted. The through hole 63a is fitted through the notch 63b to the tip or rear end or the injection needle, and the contamination prevention tool 63 is inserted. In this way, the contamination prevention device 63 is set last, so that it can be attached and removed after the injection, and when the contamination prevention device 63 becomes saturated with the leaked infusion, it can be removed and a new contamination prevention device installed. can be exchanged with other fluids and fluid administration can be continued without interruption.
以上の実施例のほか、本発明の技術思想に基づいて種々
の変形が可能である。例えば、本発明に基づく輸液装置
は、高カロリー輸液投与のほか、前述した経腸輸液投与
にも適用できることは言うまでもない。また、輸液導管
に分岐管を取付ける際、輸液導管の一部で内、外径に大
きくして輸液滞留部を設け、この部分に前記実施例と同
様にして分岐管を接続し、この部分に汚染防止具を取付
けるようにすることも可能である。In addition to the embodiments described above, various modifications can be made based on the technical idea of the present invention. For example, it goes without saying that the infusion device based on the present invention can be applied not only to high-calorie infusion administration but also to the aforementioned enteral infusion administration. In addition, when attaching a branch pipe to the infusion conduit, a part of the infusion conduit is enlarged in inner and outer diameters to provide an infusion retention part, and the branch pipe is connected to this part in the same manner as in the previous embodiment. It is also possible to attach contamination prevention equipment.
へ9発明の詳細
な説明したように、本発明に基づく輸液装置は、漏液を
吸収して漏液による汚染を防止する汚染防止具を備えて
いるので、輸液が漏れたとしても、漏れた輸液による輸
液装置の汚染が起こることがない。その結果、輸液装置
は常に清浄な状態が保たれ、例えば医療用輸液の患者の
体内への投下、輸液装置の汚染を除去するためのオペレ
ータの煩わしい作業が不要となり、省力化が可能になる
。As described in detail in Section 9 of the invention, the infusion device based on the present invention is equipped with a contamination prevention device that absorbs leakage fluid and prevents contamination due to leakage. Contamination of the infusion device by infusion fluid does not occur. As a result, the infusion device is always kept clean, and the operator does not have to perform the troublesome work of dropping medical infusions into the patient's body or removing contamination from the infusion device, resulting in labor savings.
図面はいずれも本発明の実施例を示すものであって、
第1図は瓶(輸液容器)に輸液導管を接続した状態の拡
大部分断面図、
第2図は瓶に輸液導管を接続する直前の状態の拡大部分
断面図、
第3図及び第4図は瓶に輸液導管を接続した夫々他の例
による状態の拡大部分断面図、第5図は第4図の正面図
、
第6図は第4図、第5図で使用するベルトの平面図、
第7図は瓶に輸液導管を接続した更に他の例による状態
の拡大部分断面図、
第8図は第7図の正面図、
第9図は第7図、第8図で使用するベルトの平面図、
第10図は第7図の状態の他の例による平面図、第11
図は第7図、第10図で使用するベルトの平面図、
第12図及び第13図は夫々他の例による汚染防止具の
断面図、
第14図は更に他の例による汚染防止具の斜視図・
第15図は輸液装置全体の概略図、
第16図は患者の中心静脈への高カロリー輸液投与の要
領を示す概略図
である。
なお、図面に示された符号において、
1/1′7・・・・・・・・・注射針
2.12.22・・・・・・・・・フランジ3.13.
23.33.43・・・・・・・・・汚染防止具5・・
・・・・・・・キャップ
6.16・・・・・・・・・瓶(輸液容器)7.17・
・・・・・・・・輸液導管
18.28・・・・・・・・・ベルト
27・・・・・・・・・カテーテル
73・・・・・・・・・中心静脈
TPNL・・・・・・・・・高カロリー輸液である。The drawings all show embodiments of the present invention. Figure 1 is an enlarged partial sectional view of the infusion conduit connected to the bottle (infusion container), and Figure 2 is a view immediately before the infusion conduit is connected to the bottle. FIGS. 3 and 4 are enlarged partial sectional views of other examples in which an infusion conduit is connected to the bottle, FIG. 5 is a front view of FIG. 4, and FIG. 6 is an enlarged partial sectional view of the state shown in FIG. A plan view of the belt used in FIGS. 4 and 5, FIG. 7 is an enlarged partial sectional view of yet another example in which an infusion conduit is connected to a bottle, FIG. 8 is a front view of FIG. 7, and FIG. Fig. 9 is a plan view of the belt used in Figs. 7 and 8, Fig. 10 is a plan view of another example of the state shown in Fig. 7, and Fig. 11 is a plan view of the belt used in Figs.
The figures are plan views of the belts used in Figures 7 and 10, Figures 12 and 13 are cross-sectional views of pollution prevention devices according to other examples, and Figure 14 is still another example of a pollution prevention device. Perspective view: Fig. 15 is a schematic diagram of the entire infusion device, and Fig. 16 is a schematic diagram showing the procedure for administering high-calorie infusion into a patient's central vein. In addition, in the symbols shown in the drawings, 1/1'7......Injection needle 2.12.22...Flange 3.13.
23.33.43... Contamination prevention tool 5...
......Cap 6.16...Bottle (infusion container) 7.17.
......Infusion conduit 18.28...Belt 27...Catheter 73...Central vein TPNL... ...It is a high calorie infusion.
Claims (1)
管と、前記容器と輸液導管との接続部の漏液を吸収して
この漏液による汚染を防止する吸水性ポリマーより成形
された汚染防止具とを有する輸液装置。1. A container containing an infusion, an infusion conduit connected to this container, and a contamination molded from a water-absorbing polymer that absorbs leakage from the connection between the container and the infusion conduit and prevents contamination due to this leakage. An infusion device having a preventive device.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63009053A JP2615112B2 (en) | 1988-01-18 | 1988-01-18 | Infusion device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63009053A JP2615112B2 (en) | 1988-01-18 | 1988-01-18 | Infusion device |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01185266A true JPH01185266A (en) | 1989-07-24 |
JP2615112B2 JP2615112B2 (en) | 1997-05-28 |
Family
ID=11709890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63009053A Expired - Lifetime JP2615112B2 (en) | 1988-01-18 | 1988-01-18 | Infusion device |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2615112B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009023715A (en) * | 2007-07-23 | 2009-02-05 | Mebiol Kk | Container with spout made of hydrophilic material |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5764056A (en) * | 1980-10-07 | 1982-04-17 | Baxter Travenol Lab | Protector for connecting member |
-
1988
- 1988-01-18 JP JP63009053A patent/JP2615112B2/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5764056A (en) * | 1980-10-07 | 1982-04-17 | Baxter Travenol Lab | Protector for connecting member |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009023715A (en) * | 2007-07-23 | 2009-02-05 | Mebiol Kk | Container with spout made of hydrophilic material |
Also Published As
Publication number | Publication date |
---|---|
JP2615112B2 (en) | 1997-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2169689C (en) | Sterile medical injection port and cover | |
US4998921A (en) | Intermittent I.V. therapy needle sheath | |
US10449575B2 (en) | Integrated cleaning and disinfection device, system and method | |
US4865583A (en) | Combination blood sampling and intravenous infusion apparatus and method | |
US3848603A (en) | Antiseptic catheter | |
US6299609B1 (en) | Methods and apparatus for inhibiting infection of subcutaneously implanted devices | |
US4981464A (en) | Plug device for a transfusible fluid container | |
EP0381673A1 (en) | Protective catheter sleeve. | |
US6364847B1 (en) | Blood sampling device | |
CN107096112A (en) | A kind of indwelling emergency treatment conduit thrombosis prevention device | |
US3314427A (en) | Intravenous catheter apparatus | |
JPH01185266A (en) | Liquid transfusion device | |
JP4180669B2 (en) | Infusion device | |
CN210644755U (en) | Remaining needle | |
CN210186164U (en) | Special infusion set of department of general surgery's nursing | |
CN215083381U (en) | Venous indwelling needle with fixed single-hand clamp | |
CN213312454U (en) | Remaining needle device for preventing blood return | |
CN215460860U (en) | Disposable venous transfusion needle-free transfusion device | |
CN211611055U (en) | Infusion device | |
CN213667163U (en) | Suppurative arthritis continuous negative pressure drainage irrigator | |
CN217566998U (en) | Venous indwelling needle with transfusion connector protection disinfection cap | |
CN220530378U (en) | Intravenous catheter interface disinfection box | |
CN213964628U (en) | Transfusion system | |
CN217612248U (en) | Comfortable type prevention of liquid leakage anal canal | |
CN211561379U (en) | Patient indwelling needle for pediatric clinic |